Furthermore, consistent with the growth arrest of the cells in the G0/G1 phase, the expression of p16, a CDK4/CDK6 inhibitor, was found to be upregulated in medulloblastoma cells upon miR-193a expression (Fig. 4e). The gene discussed is CDK4; the disease is medulloblastoma.